Moberg Pharma AB (MOB)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Moberg Pharma AB (MOB) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011244
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:41
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Moberg Pharma AB (Moberg Pharma), formerly Moberg Derma AB is a pharmaceutical company that offers medical products for the treatment of skin diseases. The company offers products which include Emtrix, Nalox and Naloc, Kerasal nail, Kerasal foot ointment, Domeboro, Blamex and Balmex adult care. It offers Kerasal nail for discolored and fungus-damaged nails and Kerasal foot ointment for dry and cracked heels. Moberg Pharma’s Domeboro is used for treatment of minor skin irritations. The company works in collaboration to develop Oral mucositis for the treatment of pain in the oral cavity. It markets its products in Europe, South America, Africa, the Middle East and others. Moberg Pharma is headquartered in Stockholm, Sweden.

Moberg Pharma AB (MOB) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Moberg Pharma AB, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Moberg Pharma AB, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Moberg Pharma AB, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Moberg Pharma AB, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Moberg Pharma AB, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Moberg Pharma AB, Medical Equipment, Deal Details 10
Equity Offering 10
Moberg Pharma to Raise USD16 Million in Private Placement of Shares 10
Moberg Pharma Raises USD8.6 Million in Private Placement of Shares 12
Moberg Pharma Completes Rights Offering Of Shares For US$5 Million 14
Moberg Pharma AB – Key Competitors 15
Moberg Pharma AB – Key Employees 16
Moberg Pharma AB – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Financial Announcements 18
Nov 13, 2017: Moberg Pharma interim report January – September 2017 18
Aug 08, 2017: Moberg Pharma: interim report January- June 2017 20
May 09, 2017: Moberg Pharma interim report January – March 2017 22
Feb 14, 2017: Moberg Pharma Year-end report 2016 23
Nov 08, 2016: Moberg Pharma Interim Report January-September 2016 25
Aug 09, 2016: Moberg Pharma Interim Report January – June 2016 27
May 10, 2016: Moberg Pharma: Interim Report January – March 2016 29
Feb 17, 2016: Moberg Pharma Announces Year-End Report for 2015 31
Corporate Communications 35
Sep 22, 2017: Addition to Moberg Pharma´s management team 35
Nov 04, 2016: Moberg Pharma’s Nomination Committee Appointed 36
Jan 08, 2016: Change in Moberg Pharma´s Nomination Committee 37
Legal and Regulatory 38
Feb 23, 2016: Moberg Pharma Publishes Bond Prospectus and Applies for Listing of Its Bond Loan on Nasdaq Stockholm 38
Government and Public Interest 39
Feb 23, 2016: Moberg Pharma Publishes Bond Prospectus and Applies for Listing of Its Bond Loan on Nasdaq Stockholm 39
Product News 40
Jan 18, 2017: Moberg Pharma Expands New Skin Retail Presence 40
Appendix 41
Methodology 41
About GlobalData 41
Contact Us 41
Disclaimer 41

List of Tables
Moberg Pharma AB, Medical Equipment, Key Facts, 2016 2
Moberg Pharma AB, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Moberg Pharma AB, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Moberg Pharma AB, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Moberg Pharma AB, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Moberg Pharma AB, Deals By Market, 2011 to YTD 2017 8
Moberg Pharma AB, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Moberg Pharma to Raise USD16 Million in Private Placement of Shares 10
Moberg Pharma Raises USD8.6 Million in Private Placement of Shares 12
Moberg Pharma Completes Rights Offering Of Shares For US$5 Million 14
Moberg Pharma AB, Key Competitors 15
Moberg Pharma AB, Key Employees 16
Moberg Pharma AB, Subsidiaries 17

★海外企業調査レポート[Moberg Pharma AB (MOB)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Fukoku Mutual Life Insurance Company
    Fukoku Mutual Life Insurance Company - Strategy, SWOT and Corporate Finance Report Summary Fukoku Mutual Life Insurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Zimmer Biomet Holdings Inc.:企業のM&A・事業提携・投資動向
    Zimmer Biomet Holdings Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Zimmer Biomet Holdings Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Valecha Engineering Ltd:企業の戦略・SWOT・財務情報
    Valecha Engineering Ltd - Strategy, SWOT and Corporate Finance Report Summary Valecha Engineering Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Oil India Limited:企業の戦略・SWOT・財務分析
    Oil India Limited - Strategy, SWOT and Corporate Finance Report Summary Oil India Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Tupperware Brands Corporation:企業の戦略・SWOT・財務分析
    Tupperware Brands Corporation - Strategy, SWOT and Corporate Finance Report Summary Tupperware Brands Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • MedEquities Realty Trust, Inc. (MRT):企業の財務・戦略的SWOT分析
    MedEquities Realty Trust, Inc. (MRT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Bri-Chem Corp (BRY):石油・ガス:M&Aディール及び事業提携情報
    Summary Bri-Chem Corp (Bri-Chem) is an oil and gas drilling fluids provider. It manufactures, blends, packs and conducts wholesale distribution of oilfield drilling, completion, stimulation and production chemical fluids. The company supplies custom blended cementing, acidizing and fracturing chemic …
  • Dome Investments Public Company Limited:企業の戦略・SWOT・財務情報
    Dome Investments Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Dome Investments Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • BioMarin Pharmaceutical Inc (BMRN):企業の財務・戦略的SWOT分析
    BioMarin Pharmaceutical Inc (BMRN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • U.S. Smokeless Tobacco Company:企業の戦略・SWOT・財務情報
    U.S. Smokeless Tobacco Company - Strategy, SWOT and Corporate Finance Report Summary U.S. Smokeless Tobacco Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Gannett Co., Inc.
    Gannett Co., Inc. - Strategy, SWOT and Corporate Finance Report Summary Gannett Co., Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Suda Ltd (SUD)-製薬・医療分野:企業M&A・提携分析
    Summary Suda Ltd (Suda) is a drug delivery company that offers oro-mucosal administration solutions. The company’s products include artimist, zolpimist, SUD-001, SUD-002, SUD-003, SUD-004 and SUD-005. Its artimist is a sub-lingual spray for the treatment of p. falciparum severe paediatric malaria. S …
  • Bridgestone Corporation:企業の戦略・SWOT・財務情報
    Bridgestone Corporation - Strategy, SWOT and Corporate Finance Report Summary Bridgestone Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • NovoCure Ltd (NVCR)-製薬・医療分野:企業M&A・提携分析
    Summary NovoCure Ltd (NovoCure) is an drug company that concentrates on the development and commercialization of novel therapies for tumor treating fields. The company’s pipeline products find application in various types of cancer indications such as ovarian cancer, malignant melanoma, hepatocellul …
  • Celltrion Healthcare Co Ltd (091990):製薬・医療:M&Aディール及び事業提携情報
    Summary Celltrion Healthcare Co Ltd (Celltrion) is engaged in distributing, marketing and selling of biosimilar and biological medicines. Its products include Remsima and Truxima. Remsima is a biosimilar monoclonal antibody medication used for autoimmune diseases, including Crohn's disease (CD), ulc …
  • Fujitsu Limited:企業の戦略・SWOT・財務分析
    Fujitsu Limited - Strategy, SWOT and Corporate Finance Report Summary Fujitsu Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Neurocrine Biosciences Inc (NBIX):企業の財務・戦略的SWOT分析
    Neurocrine Biosciences Inc (NBIX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Aarhus University-製薬・医療分野:企業M&A・提携分析
    Summary Aarhus University (Aarhus) is a university that undertakes activities related to research, talent development, knowledge exchange and education. The university offers bachelor’s degree programmes, master’s degree programmes and PhD programmes in various disciplines. Its areas of academic int …
  • PDL BioPharma Inc (PDLI)-製薬・医療分野:企業M&A・提携分析
    Summary PDL BioPharma Inc (PDL) formerly Protein Design Labs, Inc., manages a portfolio of patents and royalty assets that include Queen et al. patents and license agreements with various pharmaceutical and biotechnology companies, and royalty and other acquired assets. It offers financing solutions …
  • In’Tech Medical SAS:医療機器:M&Aディール及び事業提携情報
    Summary In'Tech Medical SAS (In'Tech Medical) is a medical device company that offers surgical equipment. The company designs, develops and manufactures orthopedic implants and instruments for the healthcare sector. Its surgical instruments include benders, calipers, cervical pin distractor, angled …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆